Suppr超能文献

长寿相关的FOXO3基因分型及其对日本裔、白人和黑人冠心病死亡率的影响:对三个美国人群的前瞻性研究

Longevity-Associated FOXO3 Genotype and its Impact on Coronary Artery Disease Mortality in Japanese, Whites, and Blacks: A Prospective Study of Three American Populations.

作者信息

Willcox Bradley J, Morris Brian J, Tranah Gregory J, Chen Randi, Masaki Kamal H, He Qimei, Willcox D Craig, Allsopp Richard C, Moisyadi Stefan, Gerschenson Mariana, Davy Philip M C, Poon Leonard W, Rodriguez Beatriz, Newman Anne B, Harris Tamara B, Cummings Steven R, Liu Yongmei, Parimi Neeta, Evans Daniel S, Donlon Timothy A

机构信息

Department of Research, Kuakini Medical Center, Honolulu, Hawaii.

Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii, Honolulu.

出版信息

J Gerontol A Biol Sci Med Sci. 2017 May 1;72(5):724-728. doi: 10.1093/gerona/glw196.

Abstract

BACKGROUND

We recently reported that protection against coronary artery disease (CAD) mortality is the major contributor to longer life associated with FOXO3 genotype. The present study examined this relation in more detail.

METHODS

We performed a 15-year observational study of 3,584 older American men of Japanese ancestry from the Kuakini Honolulu Heart Program cohort and 1,595 White and 1,067 Black elderly individuals from the Health Aging and Body Composition study.

RESULTS

Multivariate Cox regression models demonstrated that carriage of the longevity-associated G allele of FOXO3 single nucleotide polymorphisms rs2802292 was a protective factor against CAD mortality in all three populations. In Japanese and Whites, but not in Blacks, the protective effect of the G allele was little changed in models adjusted for other major risk factors. Population-attributable risk (PAR) models found that the nonprotective TT genotype contributed 15%, 9%, and 3% to CAD mortality risk in Japanese, White, and Black Americans, respectively, and was one of the top three contributing factors to CAD mortality. In Japanese, this effect size was comparable with hypertension (15%), but in Whites and Blacks PAR for hypertension was higher (29% and 26%, respectively). G-allele carriers had lower plasma TNF-α than noncarriers, suggesting inflammation as a potential mediating factor for CAD mortality risk.

CONCLUSION

FOXO3 genotype is an important risk factor for CAD mortality in older populations. More research is needed to identify potential mechanisms and targets for intervention.

摘要

背景

我们最近报告称,预防冠状动脉疾病(CAD)死亡是与FOXO3基因型相关的长寿的主要因素。本研究更详细地探讨了这种关系。

方法

我们对来自夸基尼檀香山心脏项目队列的3584名日裔美国老年男性以及来自健康老龄化与身体成分研究的1595名白人及1067名黑人老年人进行了为期15年的观察性研究。

结果

多变量Cox回归模型表明,FOXO3单核苷酸多态性rs2802292的长寿相关G等位基因携带者在这三个人群中都是预防CAD死亡的保护因素。在日本人和白人中,但在黑人中并非如此,在调整了其他主要风险因素的模型中,G等位基因的保护作用变化不大。人群归因风险(PAR)模型发现,非保护性TT基因型分别占日裔、白人及美国黑人CAD死亡风险的15%、9%和3%,是CAD死亡的三大促成因素之一。在日本人中,这一效应大小与高血压相当(15%),但在白人和黑人中,高血压的PAR更高(分别为29%和26%)。G等位基因携带者的血浆TNF-α低于非携带者,提示炎症可能是CAD死亡风险的潜在介导因素。

结论

FOXO3基因型是老年人群CAD死亡的重要风险因素。需要更多研究来确定潜在机制和干预靶点。

相似文献

2
FOXO3 longevity interactome on chromosome 6.
Aging Cell. 2017 Oct;16(5):1016-1025. doi: 10.1111/acel.12625. Epub 2017 Jul 19.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Exercise-based cardiac rehabilitation for coronary heart disease.
Cochrane Database Syst Rev. 2016 Jan 5;2016(1):CD001800. doi: 10.1002/14651858.CD001800.pub3.
6
Exercise-based cardiac rehabilitation for coronary heart disease.
Cochrane Database Syst Rev. 2021 Nov 6;11(11):CD001800. doi: 10.1002/14651858.CD001800.pub4.
7
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
8
Home treatment for mental health problems: a systematic review.
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

引用本文的文献

1
Multidimensional insights about healthy aging from the cohort study for community-dwelling older adults: The SONIC study.
Geriatr Gerontol Int. 2025 Mar;25(3):346-355. doi: 10.1111/ggi.70003. Epub 2025 Feb 13.
2
The Biomarkers in Extreme Longevity: Insights Gained from Metabolomics and Proteomics.
Int J Med Sci. 2024 Oct 21;21(14):2725-2744. doi: 10.7150/ijms.98778. eCollection 2024.
6
Genetic, Social, and Lifestyle Drivers of Healthy Aging and Longevity.
Curr Genet Med Rep. 2022 Sep;10(3):25-34. doi: 10.1007/s40142-022-00205-w. Epub 2022 Sep 26.
7
FOXO3A-short is a novel regulator of non-oxidative glucose metabolism associated with human longevity.
Aging Cell. 2023 Mar;22(3):e13763. doi: 10.1111/acel.13763. Epub 2023 Jan 8.
8
FOXO3, a Resilience Gene: Impact on Lifespan, Healthspan, and Deathspan.
J Gerontol A Biol Sci Med Sci. 2022 Aug 12;77(8):1479-1484. doi: 10.1093/gerona/glac132.
9
Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis.
Front Immunol. 2022 Jun 21;13:876616. doi: 10.3389/fimmu.2022.876616. eCollection 2022.

本文引用的文献

1
The FoxO3 gene and cause-specific mortality.
Aging Cell. 2016 Aug;15(4):617-24. doi: 10.1111/acel.12452. Epub 2016 Apr 13.
3
Finding the Therapeutic Sweet Spot: Using Naturally Occurring Human Variants to Inform Drug Design.
Circ Cardiovasc Genet. 2015 Oct;8(5):637-9. doi: 10.1161/CIRCGENETICS.115.001219.
4
Association Analysis of FOXO3 Longevity Variants With Blood Pressure and Essential Hypertension.
Am J Hypertens. 2016 Nov 1;29(11):1292-1300. doi: 10.1093/ajh/hpv171.
5
Novel anti-inflammatory therapies for the treatment of atherosclerosis.
Atherosclerosis. 2015 Jun;240(2):497-509. doi: 10.1016/j.atherosclerosis.2015.04.783. Epub 2015 Apr 18.
6
FOXO3: A Major Gene for Human Longevity--A Mini-Review.
Gerontology. 2015;61(6):515-25. doi: 10.1159/000375235. Epub 2015 Mar 28.
7
Cellular and molecular biology of aging endothelial cells.
J Mol Cell Cardiol. 2015 Dec;89(Pt B):122-35. doi: 10.1016/j.yjmcc.2015.01.021. Epub 2015 Feb 2.
8
GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy.
J Gerontol A Biol Sci Med Sci. 2015 Jan;70(1):110-8. doi: 10.1093/gerona/glu166. Epub 2014 Sep 8.
9
Clinical application of whole-genome sequencing: proceed with care.
JAMA. 2014 Mar 12;311(10):1017-9. doi: 10.1001/jama.2014.1718.
10
Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway.
Cell. 2013 Sep 26;155(1):57-69. doi: 10.1016/j.cell.2013.08.034. Epub 2013 Sep 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验